Hufvudstaden AB (publ) (LON:0GW3)
120.79
-1.39 (-1.14%)
At close: Jan 5, 2026
Hufvudstaden AB Revenue
Hufvudstaden AB had revenue of 801.60M SEK in the quarter ending September 30, 2025, with 2.43% growth. This brings the company's revenue in the last twelve months to 3.27B, up 9.16% year-over-year. In the year 2024, Hufvudstaden AB had annual revenue of 3.18B with 7.35% growth.
Revenue (ttm)
3.27B SEK
Revenue Growth
+9.16%
P/S Ratio
7.59
Revenue / Employee
5.59M SEK
Employees
585
Market Cap
1.96B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.18B | 217.60M | 7.35% |
| Dec 31, 2023 | 2.96B | 215.80M | 7.86% |
| Dec 31, 2022 | 2.75B | 257.90M | 10.37% |
| Dec 31, 2021 | 2.49B | 692.20M | 38.55% |
| Dec 31, 2020 | 1.80B | -185.50M | -9.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| BAE Systems | 27.41B |